Chelsea An Attractive Take-Over Target

Chelsea Therapeutics International Ltd. (Nasdaq: CHTP) widened fourth quarter losses to 7 cents per share from 3 cents per share in the year ago period but with the recent approval of Northera, Wedbush expects the company to be an attractive acquisition target. Shares of the pharmaceutical climbed 73 cents to close at $5.95.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.